Kirkland & Ellis has successfully defended Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. in the Lipitor multidistrict litigation (MDL). Devora W. Allon, a New York-based partner with the firm, emphasized the role of factual records in the case. Plaintiffs brought in a regulatory expert who argued that the Food and Drug Administration (FDA) operates at maximum efficiency and would have met an earlier target date had it been set. The case underscored the significance of thorough documentation in pharmaceutical regulatory disputes.
For more details on Kirkland & Ellis’ defense strategy, refer to the original article.